It was interesting to see almost similar views for
"Is CAC Imaging Ready to be the Gatekeeper For Advanced Imaging in Low-Risk, Symptomatic Patients?"
Whats to disagree😀
@lesleejshaw @RonBlankstein @ChinnaiyanMD
![](https://pbs.twimg.com/media/EICw5-nX4AEaVE-.jpg)
"Do you think there is enough evidence to use CAC as the front-line test and the gatekeeper for coronary CT angiography (CCTA) in low-to-intermediate risk symptomatic patients?"
@RonBlankstein @lesleejshaw @CoronaryDoc @ChinnaiyanMD
![](https://pbs.twimg.com/media/EICxgp3W4AEC8zH.jpg)
"What are your concerns about using CAC for clinical decision-making in this population?"
@RonBlankstein @lesleejshaw @CoronaryDoc @ChinnaiyanMD @DrMarthaGulati @YaleCardiology @MichaelJBlaha
![](https://pbs.twimg.com/media/EICyGgPX0AYkJGe.jpg)
"Do you see a future for using CAC in symptomatic patients and what would be needed to make it happen?"
@RonBlankstein @lesleejshaw @CoronaryDoc @ChinnaiyanMD @DrMarthaGulati @YaleCardiology @MichaelJBlaha
![](https://pbs.twimg.com/media/EICysTLWkAETXOf.jpg)
@RonBlankstein @lesleejshaw @CoronaryDoc @ChinnaiyanMD @DrMarthaGulati @YaleCardiology @MichaelJBlaha
![](https://pbs.twimg.com/media/EICzIhSX0AAtagt.jpg)